AI MARKET SCANNING

Curis Inc

AVG HISTORICAL GAP +0.37%
MAX GAP RECORD +12.78%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $CRIS
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Aug 14, 2026 Earnings Release 2026-08-14 (AFTER CLOSE)
+12.78%
May 12, 2026 Earnings Release 2026-05-12 (AFTER CLOSE)
-3.64%
Mar 19, 2026 Earnings Release 2026-03-19 (AFTER CLOSE)
+0.00%
Nov 06, 2025 Earnings Release 2025-11-06 (AFTER CLOSE)
-7.53%
Aug 05, 2025 Earnings Release 2025-08-05 (BEFORE OPEN)
+6.88%
May 06, 2025 Earnings Release 2025-05-06 (BEFORE OPEN)
-1.63%
Nov 14, 2024 Earnings Release 2024-11-14 (BEFORE OPEN)
+0.00%
Aug 01, 2024 Earnings Release 2024-08-01 (BEFORE OPEN)
+0.00%

VOLATILITY & GAP BIAS

AVG GAP MOVE 5.0%
Bullish Gaps (5)
Bearish Gaps (5)
Neutral / Flat (0)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $CRIS

EXECUTIONS1 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
2026-08-11 🔒 PRO RADAR ••• x• $•••.•• → $•••.•• 19m +0.66%
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Curis, Inc. engages in the development and commercialization of drug candidates for the treatment of human cancers. Its pipeline includes CUDC-907, CA-4948, CA-170 and CA-327. The CUDC-907 pipeline is an orally available small molecule inhibitor of HDAC and PI3K enzymes. The CA-170 pipeline is an also an orally-available small molecule…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗